SPRING VALLEY, N.Y., April 18 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. will be presenting at the 2006 UBS Global Specialty Pharmaceuticals Conference on Tuesday, April 25, at 11:00 am EDT at The Grand Hyatt New York.
The audio-only live webcast will be accessible through the UBS website at www.ibb.ubs.com or through the Par Pharmaceutical website at www.parpharm.com. A replay will be available at the same link address until May 25, 2006, and will begin 3 hours after the presentation.
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. In 2005, Par received approval for and introduced Megace(R) ES, its first branded pharmaceutical product, and expects to launch its second in 2006. Par’s Generic Products Division is committed to providing high-quality pharmaceuticals that are affordable and accessible to patients. Par manufactures, markets or licenses more than 110 generic drugs. For press release and other company information, visit www.parpharm.com
Par Pharmaceutical Companies, Inc.
CONTACT: Stephen J. Mock, or Cecelia C. Heer, both of Par PharmaceuticalCompanies, Inc., +1-201-802-4000
Web site: http://www.parpharm.com/
